Regulations.gov document
Congressional Report: Feasibility and Cost of a New Monograph System for Marketed…
Other · FDA-2003-D-0030 · posted Jun 7, 2006
Key facts
| Document ID | FDA-2003-D-0030-0007 |
|---|---|
| Title | Congressional Report: Feasibility and Cost of a New Monograph System for Marketed Unapproved Drugs |
| Document type | Other |
| Subtype | RPT-Report (outside of agency unless indicated) |
| Agency | FDA |
| Docket | FDA-2003-D-0030 |
| Posted | Jun 7, 2006 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: